Trevor Hallam Sutro Biopharma, Inc. (STRO) insider trading activity

Trevor Hallam is Pres. Rsrch & Cf. Sctific Ofcr of SUTRO BIOPHARMA, INC.. Currently has a direct ownership of 100,368 shares of STRO, which is worth approximately $251,923. The most recent transaction as insider was on Apr 14, 2023, when has been sold 1,296 shares (Common Stock) at a price of $4.4 per share, resulting in proceeds of $5,702. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K

0% 3M change

0% 12M change

Total Value Held $251,923

Trevor Hallam Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 14 2023	SELL Payment of exercise price or tax liability	$5,702 $4.4 p/Share	1,296 Reduced 1.27%	100,368 Common Stock
Apr 14 2023	BUY Exercise of conversion of derivative security	-	3,750 Added 3.56%	101,664 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$44,681 $5.79 p/Share	7,717 Reduced 7.31%	97,914 Common Stock
Mar 03 2023	BUY Exercise of conversion of derivative security	-	22,250 Added 17.4%	105,631 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$16,050 $7.5 p/Share	2,140 Reduced 2.5%	83,381 Common Stock
Jan 27 2023	BUY Exercise of conversion of derivative security	-	5,250 Added 5.78%	85,521 Common Stock
Apr 14 2022	SELL Payment of exercise price or tax liability	$9,409 $7.26 p/Share	1,296 Reduced 1.59%	80,271 Common Stock
Apr 14 2022	BUY Exercise of conversion of derivative security	-	3,750 Added 4.4%	81,567 Common Stock
Mar 05 2022	SELL Payment of exercise price or tax liability	$34,951 $8.17 p/Share	4,278 Reduced 5.21%	77,817 Common Stock
Mar 05 2022	BUY Exercise of conversion of derivative security	-	12,500 Added 13.21%	82,095 Common Stock
Jan 29 2022	SELL Payment of exercise price or tax liability	$22,349 $10.39 p/Share	2,151 Reduced 3.0%	69,595 Common Stock
Jan 29 2022	BUY Exercise of conversion of derivative security	-	5,250 Added 6.82%	71,746 Common Stock
Sep 24 2021	SELL Payment of exercise price or tax liability	$73,266 $19.23 p/Share	3,810 Reduced 5.42%	66,496 Common Stock
Sep 24 2021	BUY Exercise of conversion of derivative security	-	11,019 Added 13.55%	70,306 Common Stock
Jan 29 2021	SELL Payment of exercise price or tax liability	$46,072 $22.15 p/Share	2,080 Reduced 3.39%	59,287 Common Stock
Jan 29 2021	BUY Exercise of conversion of derivative security	-	5,250 Added 7.88%	61,367 Common Stock
Jan 26 2021	SELL Open market or private sale	$61,955 $25.89 p/Share	2,393 Reduced 4.09%	56,117 Common Stock
Jan 26 2021	BUY Exercise of conversion of derivative security	$10,433 $4.36 p/Share	2,393 Added 3.93%	58,510 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$84,606 $4.36 p/Share	19,405 Added 25.69%	56,117 Common Stock
Dec 28 2020	SELL Open market or private sale	$53,531 $22.37 p/Share	2,393 Reduced 6.12%	36,712 Common Stock
Dec 28 2020	BUY Exercise of conversion of derivative security	$10,433 $4.36 p/Share	2,393 Added 5.77%	39,105 Common Stock
Nov 27 2020	SELL Open market or private sale	$40,705 $17.01 p/Share	2,393 Reduced 6.12%	36,712 Common Stock
Nov 27 2020	BUY Exercise of conversion of derivative security	$10,433 $4.36 p/Share	2,393 Added 5.77%	39,105 Common Stock
Nov 05 2020	SELL Open market or private sale	$251,265 $15.0 p/Share	16,751 Reduced 31.33%	36,712 Common Stock
Nov 05 2020	BUY Exercise of conversion of derivative security	$73,034 $4.36 p/Share	16,751 Added 23.86%	53,463 Common Stock

Trevor Hallam

Pres. Rsrch & Cf. Sctific Ofcr

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STRO shares.

Notify only if

Value

Insider Trading

Get notified when an Sutro Biopharma, Inc. insider buys or sells STRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SUTRO BIOPHARMA, INC.

Track Activities on STRO

Account